Vaishali Pharma Share Price
Start SIP in Vaishali Pharma
Start SIPVaishali Pharma Performance
Day Range
- Low 184
- High 194
52 Week Range
- Low 118
- High 204
- Open Price188
- Previous Close185
- Volume336813
Vaishali Pharma Investment Rating
-
Master Rating:
-
Vaishali Pharma has an operating revenue of Rs. 90.94 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 14% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 18 | 32 | 28 | 13 | 13 | 26 |
| Operating Expenses Qtr Cr | 16 | 39 | 25 | 10 | 11 | 25 |
| Operating Profit Qtr Cr | 2 | -7 | 3 | 3 | 2 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 1 |
| Tax Qtr Cr | 1 | -2 | 1 | 1 | 1 | 0 |
| Net Profit Qtr Cr | 2 | -5 | 2 | 2 | 2 | 0 |
Vaishali Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹177.14
- 50 Day
- ₹167.85
- 100 Day
- ₹162.51
- 200 Day
- ₹157.00
- 20 Day
- ₹174.64
- 50 Day
- ₹164.61
- 100 Day
- ₹159.83
- 200 Day
- ₹160.75
Vaishali Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 189.85 |
| Second Resistance | 194.96 |
| Third Resistance | 198.34 |
| RSI | 60.12 |
| MFI | 79.53 |
| MACD Single Line | 6.55 |
| MACD | 7.42 |
| Support | |
|---|---|
| First Support | 181.36 |
| Second Support | 177.98 |
| Third Supoort | 172.87 |
Vaishali Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 169,674 | 9,192,937 | 54.18 |
| Week | 269,541 | 15,363,814 | 57 |
| 1 Month | 478,865 | 23,119,588 | 48.28 |
| 6 Month | 196,902 | 10,711,456 | 54.4 |
Vaishali Pharma Result Highlights
Vaishali Pharma Synopsis
NSE-Medical-Diversified
Vaishali Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 69.66 Cr. and Equity Capital is Rs. 10.55 Cr. for the Year ended 31/03/2023. Vaishali Pharma Ltd. is a Public Limited Listed company incorporated on 25/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L52310MH2008PLC181632 and registration number is 181632.| Market Cap | 287 |
| Sales | 91 |
| Shares in Float | 1.06 |
| No of funds | 2 |
| Yield |
| Book Value | 4.62 |
| U/D Vol ratio | 2.7 |
| LTDebt / Equity | 8 |
| Alpha | 0.13 |
| Beta | 0.55 |
Vaishali Pharma Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|
| Promoters | 26.32% | 26.32% | 26.62% |
| Foreign Portfolio Investors | |||
| Individual Investors | 66.11% | 62.93% | 60.94% |
| Others | 7.57% | 10.75% | 12.44% |
Vaishali Pharma Management
| Name | Designation |
|---|---|
| Mr. Atul Vasani | Chairman & Managing Director |
| Mr. Dewansh Vasani | Executive Director |
| Mrs. Jagruti Vasani | Whole Time Director |
| Mr. Ashvin Ganatra | Independent Director |
| Mr. Manish Ved | Independent Director |
| Mr. Pratik Jakhelia | Independent Director |
Vaishali Pharma Forecast
Price Estimates
Vaishali Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-28 | Bonus issue, Stock Split & Fund Raising | To consider the proposal for raising of fund by way of equity shares, debentures or other securities through rights issue, private placement, qualified institutions placement (QIP), preferential issue issue in the ratio of 3:5 of Rs. 10/- |
| 2024-08-14 | Quarterly Results | |
| 2024-02-02 | Quarterly Results | |
| 2023-11-08 | Quarterly Results | |
| 2023-08-07 | Quarterly Results |
Vaishali Pharma FAQs
What is Share Price of Vaishali Pharma ?
Vaishali Pharma share price is ₹192 As on 09 September, 2024 | 16:09
What is the Market Cap of Vaishali Pharma ?
The Market Cap of Vaishali Pharma is ₹299.6 Cr As on 09 September, 2024 | 16:09
What is the P/E ratio of Vaishali Pharma ?
The P/E ratio of Vaishali Pharma is 360.1 As on 09 September, 2024 | 16:09
What is the PB ratio of Vaishali Pharma ?
The PB ratio of Vaishali Pharma is 7 As on 09 September, 2024 | 16:09